Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.

A person looking at MRI and CT scans on a  computer

Study Discovers Overdiagnosis of Progressive Cancer in Routine Clinical Evaluations

A recent retrospective study led by Dr. Marilyn J. Siegel and her team at the Washington University School of Medicine in St. Louis has shed light on a critical issue in cancer care: routine clinical reads are more prone to overdiagnosing progressive disease when compared to RECIST 1.1 interpretations. This discrepancy holds significant implications, potentially leading to the premature discontinuation of effective treatments for cancer clinical trial participants and patients under standard care.

In this study, mint Lesion software was utilized for the criteria-based reads, determining overall response assessments according to RECIST 1.1 criteria, and generating structured reports for the clinical trial's principal investigator.

To learn more about the study's insights into the discrepant assessments and the suggested steps for mitigating this issue, click here

Related Resources

Related Resources

A picture of Prof. Dr. Thorsten Persigehl next to a quote on the importance of mint Lesion™ for radCIO

Challenges and Opportunities of Setting Up a Comprehensive Oncological Imaging Database

In an exclusive interview with Prof. Dr. Thorsten Persigehl, a leading expert in Oncological Imaging, we delved into the transformative radCIO project…

Interview with Prof. Thorsten Persigehl on the radCIO in Cologne

Structured data in radiology is crucial for accurate diagnoses and treatment planning and serves as the basis for detailed clinical practice and…

Several juxtaposed images of different patients with different responses to the cancer treatment

Study with mint Lesion™ compares the Efficacy of SIRT and CS-PHP in Uveal Melanoma with Hepatic Metastasis

A study conducted by researchers at University Hospital Tuebingen retrospectively compared two liver-targeted therapies for uveal melanoma patients…